Letter to the Editor
Identifying alcoholic liver disease patients using electronic health records within an integrated health system
Translational Gastroenterology and Hepatology
2024;
9:
77
(30 October 2024)
Case Report
An acute progressing hepatic angiosarcoma in a young male diagnosed by contrast-enhanced ultrasound-guided liver needle biopsy: a case report
Translational Gastroenterology and Hepatology
2024;
9:
76
(30 October 2024)
Review Article
The integration of complementary and integrative health and whole person health in gastrointestinal disorders: a narrative review
Translational Gastroenterology and Hepatology
2024;
9:
75
(30 October 2024)
Review Article
Cultural considerations in gastroenterology: barriers to care and a call for humility and action
Translational Gastroenterology and Hepatology
2024;
9:
74
(30 October 2024)
Review Article
We didn’t start the fire...or did we?—a narrative review of medical gaslighting and introduction to medical invalidation
Translational Gastroenterology and Hepatology
2024;
9:
73
(30 October 2024)
Review Article
Predicting waitlist dropout in hepatocellular carcinoma: a narrative review
Translational Gastroenterology and Hepatology
2024;
9:
72
(30 October 2024)
Review Article
Idiopathic acute pancreatitis (IAP)—a review of the literature and algorithm proposed for the diagnostic work-up of IAP
Translational Gastroenterology and Hepatology
2024;
9:
71
(30 October 2024)
Review Article
Hepatobiliary anastomotic leakage: a narrative review of definitions, grading systems, and consequences of leaks
Translational Gastroenterology and Hepatology
2024;
9:
70
(30 October 2024)
Review Article
Eosinophilic gastrointestinal disorders: a narrative review on clinical perspectives and research gaps in the Asian context
Translational Gastroenterology and Hepatology
2024;
9:
69
(30 October 2024)
Review Article
Heart rate variability in acute pancreatitis: a narrative review
Translational Gastroenterology and Hepatology
2024;
9:
68
(30 October 2024)
Review Article
Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease
Translational Gastroenterology and Hepatology
2024;
9:
67
(30 October 2024)
Original Article
Isosteviol plays a protective role on hepatic ischemia and reperfusion injury in mice through MAPK/NF-κB signaling pathway
Translational Gastroenterology and Hepatology
2024;
9:
66
(30 October 2024)
Original Article
Systematic metabolic profiling of mice with caerulein-induced acute pancreatitis
Translational Gastroenterology and Hepatology
2024;
9:
65
(30 October 2024)
Original Article
Landscape of surgery in Crohn’s disease across twenty years: insights from machine learning
Translational Gastroenterology and Hepatology
2024;
9:
64
(30 October 2024)
Original Article
Liver transplantation for hepatocellular carcinoma: a proposal for including preoperative serological indicators improves the Milan criteria expanded
Translational Gastroenterology and Hepatology
2024;
9:
63
(30 October 2024)
Original Article
REGγ deficiency ameliorates hepatic ischemia and reperfusion injury in a mitochondrial p66shc dependent manner in mice
Translational Gastroenterology and Hepatology
2024;
9:
62
(30 October 2024)
Original Article
Heterogeneity and prognosis of single organ metastases in gastric cancer
Translational Gastroenterology and Hepatology
2024;
9:
61
(30 October 2024)
Editorial Commentary
A new era with advanced immunotherapy
Translational Gastroenterology and Hepatology
2024;
9:
60
(30 October 2024)
Editorial Commentary
Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer
Translational Gastroenterology and Hepatology
2024;
9:
59
(30 October 2024)
Editorial Commentary
Importance of magnetic resonance imaging and positron emission tomography as preoperative staging tests prior to liver resection
Translational Gastroenterology and Hepatology
2024;
9:
58
(30 October 2024)
Editorial Commentary
Yes, you should do a magnetic resonance imaging (MRI) for patients scheduled for local therapy of colorectal cancer liver metastases: insights into the CAMINO study
Translational Gastroenterology and Hepatology
2024;
9:
57
(30 October 2024)
Editorial Commentary
KRAS and EGFR inhibitors: a new step in the management of colorectal cancer
Translational Gastroenterology and Hepatology
2024;
9:
56
(30 October 2024)
Editorial Commentary
Unlocking the promise of neoadjuvant immunotherapy in gastroesophageal cancers: insights from the PANDA trial
Translational Gastroenterology and Hepatology
2024;
9:
55
(30 October 2024)
Editorial Commentary
KRAS G12C inhibitors in metastatic colorectal cancer: a tale of two targets
Translational Gastroenterology and Hepatology
2024;
9:
54
(30 October 2024)
Editorial Commentary
Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation
Translational Gastroenterology and Hepatology
2024;
9:
53
(30 October 2024)
Editorial Commentary
Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib
Translational Gastroenterology and Hepatology
2024;
9:
52
(30 October 2024)